GenomOncology has a new partnership with med fusion

October 8, 2014

GenomOncology has a new partnership with med fusion, an integrated molecular center of excellence and clinical trials service organization. Their goal is to optimize treatment strategies by including both relevant drug and clinical trial options in laboratory reports. Read the full article here.